What Transformation Has the Swine Vaccines Market Undergone?
The swine vaccines market has seen considerable growth due to a variety of factors.
• There has been robust growth in the size of the swine vaccines market in the last few years. The market is projected to expand from $2.18 billion in 2024 to $2.38 billion in 2025 with a compound annual growth rate (CAGR) of 8.9%. Factors such as disease outbreaks, economic losses, government regulations, and a rise in swine production have contributed to this growth in the historical period.
What Are The Predictions for The Swine Vaccines Market?
The Swine Vaccines market is expected to maintain its strong growth trajectory in upcoming years.
• The market for swine vaccines is set to experience robust growth in the forthcoming years. Its size is projected to reach $3.44 billion by 2029, with a compound annual growth rate (CAGR) of 9.7%.
The uprise during the forecast period is primarily due to the emergence of new diseases and viral strains, the globalization of the swine industry, changes in climate and environment, implementation of biosecurity measures, and market competition. The main trends for the forecast period are the advancements in veterinary medicine, shifts in disease patterns, the worldwide protein demand, technological progress, and an emphasis on preventive healthcare.
Which Drivers Are Accelerating Growth In The Swine Vaccines Market?
The surge in swine disease occurrence is predicted to fuel the growth of the swine vaccine market. Swine disease can be described as any deviation from an organism's normal physiological or morphological state, usually coupled with various disease symptoms like pseudorabies, influenza. Swine vaccines are highly effective in battling the escalating swine disease incidents by activating the immune system to identify and counteract specific pathogens. This effectively lowers infection rates, lessens disease severity, and enhances the overall health of the herd. For example, information from the US-based Swine Health Information Center in December 2023 reveals a significant rise in African Swine Fever (ASF) among wild boars in Poland. By early 2023, the country had reported 2,347 confirmed ASF cases in wild boars, surpassing the total number recorded in 2022. Thus, the increasing swine disease cases are anticipated to trigger the swine vaccine market growth.
What Are The Core Segments Of The Global Swine Vaccines Market?
The swine vaccines market covered in this report is segmented –
1) By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA (Deoxyribonucleic Acid) Vaccines, Recombinant Vaccines
2) By Disease: Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies
4) By Application: Government Tender, Market Sales
Subsegments:
1) By Attenuated Live Vaccines: Live Attenuated Virus Vaccines, Live Attenuated Bacterial Vaccines
2) By Inactivated Vaccines: Whole Inactivated Virus Vaccines, Inactivated Bacterial Vaccines
3) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines
4) By DNA (Deoxyribonucleic Acid) Vaccines: Plasmid DNA Vaccines, Nucleic Acid Vaccines
5) By Recombinant Vaccines: Recombinant Vector Vaccines, Recombinant Protein Vaccines
Pre-Book The Swine Vaccines Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Swine Vaccines Market Size?
The emergence of technological innovations is a trending factor propelling the swine vaccine market. Leading market participants are focusing their resources on developing revolutionary technologies that can deliver dual vaccines simultaneously, aiming to improve swine health and solidify their standing in the market. Case in point, Boehringer Ingelheim, a renowned pharmaceutical company from Germany, introduced the TwistPak technology in May 2022. This breakthrough system facilitates the mixture of two vaccines, IngelvacCircoFLEX and IngelvacMycoFLEX, which are intended for swine producers. The TwistPak technology provides a streamlined, time-efficient platform that makes the mixing process easier, while preserving the option of utilizing the products as a combined vaccine or as a monovalent. The device is crafted with cutting-edge technologies and boasts of an ergonomic design.
Who Are the Key Players In The Swine Vaccines Market?
Major companies operating in the swine vaccines market include:
• Merck & Co Inc.
• Boehringer Ingelheim Animal Health USA Inc.
• Elanco Animal Health Inc.
• Biogenesis Bago SA
• Phibro Animal Health Corporation
• KM Biologics Co. Ltd.
• Hipra Laboratories SA
• Ceva Santé Animale SA
• Zoetis Inc.
• Jinyu Bio-Technology Co. Ltd.
• China Animal Husbandry Industry Co. Ltd.
• Virbac SA
• Harbin Veterinary Research Institute
• Bioveta AS
• Bimeda Holdings PLC
• Biovac Ltd.
• Hester Biosciences Limited
• Hygieia Biological Laboratories
• IDT Biologika GmbH
• Intervet Inc.
• Komipharm International Co. Ltd.
• Kyoritsu Seiyaku Corporation
• Lohmann Animal Health International
• Norbrook Laboratories Limited
• Ouro Fino Saúde Animal SA
• Prondil SA
• Vaxxinova International BV
• Vetoquinol SA
• Veyx Pharma GmbH
• Tianjin Ringpu Bio-Technology Co. Ltd.
What Are The Regional Insights Into The Swine Vaccines Market?
North America was the largest region in the swine vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
